CIK 0001501989 · Accelerated filer
CytomX Therapeutics, Inc.
Sign in to watch- Ticker
- CTMX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 273521219
- Phone
- 650.515.3185
- Business address
- 151 OYSTER POINT BLVD., SUITE 400, SOUTH SAN FRANCISCO, CA, 94080
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2017-11-30 | RAY DEBANJAN Chief Financial Officer | Grant or award | +163 | $12.15 | $2K | 12,289 |
| 2017-11-30 | McCarthy Sean A. President and CEO | Grant or award | +398 | $12.15 | $5K | 4,643 |
| 2017-11-01 | McCarthy Sean A. President and CEO | Option exercise | +14,342 | $0.95 | $14K | 18,587 |
| 2017-11-01 | McCarthy Sean A. President and CEO | Sale | −14,342 | $19.86 | $285K | 4,245 |
| 2017-11-01 | McCarthy Sean A. President and CEO | Option exercise · Stock Option (right to buy) | −14,342 | 119,293 | ||
| 2017-11-01 | RAY DEBANJAN Chief Financial Officer | Sale | −2,500 | $20.00 | $50K | 12,126 |
| 2017-10-23 | Fuchs Charles S. Director | Grant or award · Stock Option (right to buy) | +28,000 | 28,000 | ||
| 2017-10-18 | THIRD ROCK VENTURES LP 10% owner | Other disposition | −1,000,000 | 3,320,348 | ||
| 2017-10-04 | McCarthy Sean A. President and CEO | Option exercise | +19,120 | $0.95 | $18K | 23,365 |
| 2017-10-04 | McCarthy Sean A. President and CEO | Sale | −19,120 | $24.13 | $461K | 4,245 |
| 2017-10-04 | McCarthy Sean A. President and CEO | Option exercise · Common Stock | −19,120 | 133,635 | ||
| 2017-10-04 | Kavanaugh William Michael CSO, Head Res.&Non-Clin. Dev. | Option exercise | +48,368 | $4.47 | $216K | 62,285 |
| 2017-10-04 | Kavanaugh William Michael CSO, Head Res.&Non-Clin. Dev. | Sale | −48,368 | $24.34 | $1.2M | 13,917 |
| 2017-10-04 | Kavanaugh William Michael CSO, Head Res.&Non-Clin. Dev. | Option exercise · Stock Option (Right to Buy) | −48,368 | 48,368 | ||
| 2017-10-04 | GLUCK FREDERICK W Director | Sale | −10,000 | $24.27 | $243K | 311,643 |
| 2017-10-04 | TEPPER ROBERT I 10% owner | Sale | −24,777 | $24.34 | $603K | 29,516 |
| 2017-10-02 | McCarthy Sean A. President and CEO | Option exercise | +9,562 | $0.95 | $9K | 13,807 |
| 2017-10-02 | McCarthy Sean A. President and CEO | Sale | −9,562 | $18.57 | $178K | 4,245 |
| 2017-10-02 | McCarthy Sean A. President and CEO | Option exercise · Stock Option (right to buy) | −9,562 | 15,481 | ||
| 2017-10-02 | RAY DEBANJAN Chief Financial Officer | Sale | −2,500 | $18.10 | $45K | 14,626 |
Page 22 of 33 · 649 trades